Basic and Translational Research on HPV-Related Malignancies
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Pathophysiology".
Deadline for manuscript submissions: closed (31 August 2021) | Viewed by 20954
Special Issue Editors
2. Postgraduate Programme in Adult Health (PPGSAD), Department of Morphology, Federal University of Maranhão (UFMA), and UFMA University Hospital (HUUFMA), 65080-805 São Luís, Brazil
Interests: cancer cachexia; animal models of cancer
Special Issues, Collections and Topics in MDPI journals
Interests: animal models, in vivo studies, natural compounds,
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear colleagues,
The development of HPV vaccines has changed the paradigm of cervical cancer prevention and, in combination with screening programmes, is expected to have a major impact on cancer incidence. However, many developing countries still experience significant difficulties in implementing HPV vaccination and screening. Additionally, the incidence of other HPV-related cancers, especially HPV+ head-and-neck squamous cell carcinoma, is rising alarmingly. The prognosis for advanced and metastatic HPV-related cancers remains poor, and there is a need for less-toxic and more effective therapies.
This Special Issue will address basic and translational studies on all HPV-related malignancies, including cervical cancer, HPV+ head-and-neck cancer, and other anogenital cancers like anal and penile cancers. The scope of this Issue is broad, ranging from basic mechanistic studies to pre-clinical trials of potential new therapies. In vivo studies involving animal models of disease and works based on alternative models (e.g., 3D cell culture, organ on a chip) are particularly welcomed, as well as works dealing with less-studied lesions such as penile cancer.
Dr. Rui M. Gil da Costa
Dr. Paula A. Oliveira
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- HPV
- translational research
- basic research
- pre-clinical